Arecor Therapeutics plc

Arecor is a biopharmaceutical company that develops medicines for diabetes and other chronic conditions using its Arestat™ technology platform.
  • Differentiated biosimilars
  • Arestat™ technology platform
  • Ultra-Rapid Acting Insulin (AT247)
  • Thermostable vaccines and therapeutics
  • Ultra-Concentrated Ultra-Rapid Acting Insulin (AT278)
Size
Small
Phone
+44 1223 426060
Website
arecor.com
Email
N/A
Locations
41 Lothbury, EC2R 7HG
Chesterford Research Park, CB10 1XL
01223426060
Digital Popularity
Social Media
Competitors
CHAIN Biotech
CHAIN Biotech develops oral vaccines and immuno-therapies targeting the lower gastrointestinal tract, with several therapeutic candidates in pre-clinical development.
Company Details
Arecor Therapeutics plc is operated by Arecor Therapeutics Plc and is a Active company incorporated on 13 April 2021 with the registered office located in Saffron Walden, Essex. Arecor Therapeutics Plc was registered 4 years ago.
Status
Active
Size
Small
Directors
7
Age
4 years old
Employees
44
Turnover
£5.05M
Total Assets
£8.72M
Cash in Bank
£3.24M
Total Liabilities
-£3.37M
Simon John Ormiston
Director • British • Lives in UK • Born in Jul 1973
David John Ellam
Director • Secretary • Cfo • British • Lives in England • Born in Oct 1963
Jeremy Lewis Morgan
Director • British • Lives in UK • Born in Jun 1963
Dr Sarah Jennifer Howell
Director • Chief Executive Officer • British • Lives in England • Born in Oct 1975
Andrew Richards
Director • British • Lives in England • Born in Mar 1960
Mohammad Sohail Fazeli
Director • Senior Pharmaceutical Analyst • British • Lives in England • Born in Jul 1964
More information on Arecor Therapeutics Plc
Teams
All
31
Management
18
Research
9
Administration
2
Compliance
1
Other
5
David Gerring
Vice President Of Development • Joined Apr 2020
Sarah Howell
Chief Executive Officer • Joined May 2015
Lane Andrew
Non Executive Director • Joined Jul 2007
Jeremy Morgan
Non Executive Director • Joined Jun 2021
Sam Fazeli
Non Executive Director • Joined Sep 2017
Jan Jezek
Chief Scientific Officer • Joined Aug 2007
Manjit Rahelu
Chief Business Officer • Joined Apr 2023
Sheena Singadia
Formulation Lead • Joined Oct 2024
Maggie McConnell
Executive Assistant • Joined Oct 2018
Jorge Pinto
Associate Director • Joined Oct 2024
David Gerring
Vice President Of Development • Joined Apr 2020
Sarah Howell
Chief Executive Officer • Joined May 2015
Lane Andrew
Non Executive Director • Joined Jul 2007
Jeremy Morgan
Non Executive Director • Joined Jun 2021
Sam Fazeli
Non Executive Director • Joined Sep 2017
Jan Jezek
Chief Scientific Officer • Joined Aug 2007
Manjit Rahelu
Chief Business Officer • Joined Apr 2023
Sheena Singadia
Formulation Lead • Joined Oct 2024
Jorge Pinto
Associate Director • Joined Oct 2024
Joshua Cremin
Senior Formulation Lead • Joined Oct 2024
Jan Jezek
Chief Scientific Officer • Joined Aug 2007
Katerina-Asteria Rousou
Scientist II, Diabetes And Obesity • Joined Jun 2021
Ilaria Passarini
Senior Scientist • Joined Sep 2022
Monish Suratwala
Senior Scientist • Joined Mar 2022
Carolyn Tucker
Senior Scientist
Rafic Sukar, AMRSC
Formulation Chemist • Joined Dec 2021
William George Saunders
Scientist II • Joined Nov 2024
Andrea Tenslin
Formulation Scientist • Joined May 2022
Nikitha P
Scientist 1 • Joined Jul 2023
Maggie McConnell
Executive Assistant • Joined Oct 2018
Harma Marriott
Office Manager • Joined Aug 2022
Natalie Meredith
CMC Manager • Joined Jan 2022
Helen Parris
SVP Commercial And General Manager • Joined Jan 2024
Anna Salim
Investor • Joined Aug 2022
Jorge Pinto
Team Leader For Technology Partnering • Joined Nov 2019
View 31 members